Abstract

Objective: To analyze the effect of transcutaneous acupoint electrical stimulation in the treatment of chronic pelvic pain following sequelae of pelvic inflammatory diseases. Methods: Fifty cases of chronic pelvic pain patients with sequelae of pelvic inflammatory diseases, who visited the hospital between June 2022 and June 2023, were selected and randomly divided into the experimental group and control group using a computerized lottery method. The control group received treatment with painkillers, while the experimental group underwent transcutaneous acupoint electrical stimulation. Symptoms, signs, and pain levels were observed before and after the treatment, and clinical effects between the two groups were compared. Results: Patients in the experimental group exhibited lower PPI, VAS, PRI, and other pain scores compared to the control group (P < 0.05). Moreover, symptoms and signs scores in the experimental group were lower than those in the control group (P < 0.05). Following treatment, the quality-of-life scores for patients in the experimental group were higher than those in the control group (P < 0.05). The experimental group had a higher overall treatment effective rate of 96% as compared to the control group (76%; P < 0.05). Conclusion: The application of transcutaneous acupoint electrical stimulation significantly reduced the degree of pelvic pain in patients with sequelae of pelvic inflammatory diseases. This intervention enhanced the overall clinical effect and promoted an improvement in the patient’s quality of life.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call